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Abstract 
Background. Fractionated bilirubin requires more blood (0.6 ml) than total bilirubin alone (0.2 
ml). Our focus during the first week in the Neonatal Intensive Care Unit (NICU) is on prevention 
of Bilirubin Induced Neurologic Dysfunction and kernicterus, which do not require fractionation. 
We wanted to determine the benefit of knowing fractionated bilirubin in the first week. 
Methods. In this retrospective study, data were obtained from the first week for 1202 NICU 
inborn admissions. 
Results. Direct bilirubin was more than 2.0 mg/dl in only six infants (0.6%).  Five had 
multisystem injury from hypoxic ischemic events. One also had congenital cytomegalovirus and 
another had a postoperative liver hematoma. Weekly multichem profiles would have detected 
these abnormalities. No specific therapy was initiated for any of these infants. 
Conclusions. Converting to total bilirubin alone would not alter treatment, but could reduce 
iatrogenic blood loss by 2.4 ml per infant. 
KS J Med 2014; 7(4):129-131. 
 
 
Introduction 
Jaundice exists when a newborn has a 
high level of bilirubin in the blood.1 Bili-
rubin is produced from hemoglobin when 
red blood cells breakdown. While in utero, 
the placenta allows fetal unconjugated bili-
rubin to transfer to the mother for con-
jugation and excretion. After birth, the new-
born adapts and the liver begins to conjugate 
bilirubin so it can be excreted in the stool. 
The increase in conjugation takes about 
three days for full-term infants and longer 
for premature infants. The unconjugated 
bilirubin rises and causes jaundice. Most 
jaundice is not harmful; however, bilirubin 
may be a concern for infants with other 
illnesses, including prematurity. The compli-
cations of elevated bilirubin are Bilirubin 
Induced Neurologic Dysfunction (BIND) 
and a more devastating permanent syn-
drome, kernicterus.2 
The diazo reaction, the routine clinical 
testing method for serum bilirubin, identifies 
direct bilirubin, the component that reacts 
rapidly to the diazo reagent.3 With an 
accelerator, the diazo reaction measures total 
bilirubin (TB); this additional component we 
call the indirect fraction. Although highly 
variable, total bilirubin is the clinical 
surrogate used to predict the risk of BIND 
and kernicterus. Clinicians use frequent 
determinations (daily or more often) of TB 
to guide therapy.4 Therapeutic interventions 
include phototherapy and exchange trans-
fusion to reduce TB and the attendant risks 
of BIND and kernicterus.  
Direct Bilirubin (DB) results monitor the 
excretion process, which may be impaired, 
by infection or long term parenteral 
nutrition. Both disease states typically 
present later in the neonatal course.5 TB can 
be done on a blood sample of 0.2 ml used 
for blood gas and electrolyte determination. 
Fractionated bilirubin requires 0.6 ml. Daily 
or more frequent determinations of bilirubin 
are obtained in the first week to prevent 
BIND and kernicterus. Later in the course, 
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weekly monitoring of alkaline phosphatase, 
renal function, fractionated bilirubin and 
liver enzymes is obtained for those on long 
term parenteral alimentation. 
Our initial objective was to determine 
the number and results of the bilirubin 
determinations during the first seven days 
for our Neonatal Intensive Care Unit 
(NICU) admissions. The second objective 
was to determine if any clinical insight was 
gained by having the direct bilirubin results 
during this period of time. If these infants 
could be managed without fractionating the 
bilirubin in the first week, the reduction in 
iatrogenic blood loss may prevent anemia 
and reduce transfusions. 
 
Methods 
The NICU at Wesley Medical Center has 
a data warehouse for information from the 
admission, transfer, discharge summaries, 
and daily progress notes, including 
laboratory results. These codified and text 
fields are stored in a series of tables in 
Microsoft SQL. 
In this retrospective descriptive study, 
data were obtained from the first seven days 
of a convenience sample of 1202 inborn 
NICU admissions (7290 bilirubin levels) 
from January 1, 2010 to December 31, 2011. 
A threshold for DB of more than 2 mg/dl 
was set as clinically significant. Any 
specific intervention or diagnostic testing 
that was pursued in the first week related to 
any of the elevated direct bilirubin levels 
was recorded. Infants with documented 
inborn errors of metabolism, positive initial 
blood culture, or major congenital anomaly 
were excluded.  
The research dataset was de-identified to 
protect patient privacy. The project was 
approved by the Institutional Review Board. 
 
Results 
After reviewing 1201 infants (see Table 
1), only six infants (0.6%) were identified 
with DB more than 2 mg/dl in the first week. 
Of the six infants, five had multisystem 
injury from hypoxic ischemic events near 
birth. One of these also had congenital 
cytomegalovirus and one had surgery for a 
persistent vitelline duct with a liver 
hematoma. 
 
Table 1. Birth weight and gestational age of 
infants. 
 
Discussion 
Given that none of the conditions 
associated with elevated DB require targeted 
intervention during this time frame, 
conversion to TB alone in the first seven 
days of the patients in the NICU would 
reduce iatrogenic blood loss by an average 
of 2.4 ml/infant and would not alter 
treatment plans. The weekly fractioned 
bilirubin was adequate for the management 
and prevention of conditions associated with 
conjugated hyperbilirubinemia. 
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